^
Association details:
| Biomarker: | SAAL1 overexpression |
|---|---|
| Cancer: | Bladder Cancer |
| Drug Class: | PD-L1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Published date:
08/13/2022
Excerpt:
SAAL1 overexpression was also associated with immunotherapy response and overall survival (OS) in bladder cancer (BLCA) patients who had received anti-PD-L1 treatment.
DOI:
10.18632/aging.204224